Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Comparative analysis of Annexin A1-formyl peptide receptor 2/ALX expression in human leukocyte subsets.

Spurr L, Nadkarni S, Pederzoli-Ribeil M, Goulding NJ, Perretti M, D'Acquisto F.

Int Immunopharmacol. 2011 Jan;11(1):55-66. doi: 10.1016/j.intimp.2010.10.006. Epub 2010 Oct 23.

PMID:
20974309
2.

Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.

Brancaleone V, Dalli J, Bena S, Flower RJ, Cirino G, Perretti M.

J Immunol. 2011 Apr 15;186(8):4905-14. doi: 10.4049/jimmunol.1003145. Epub 2011 Mar 11.

3.

Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.

Gastardelo TS, Cunha BR, Raposo LS, Maniglia JV, Cury PM, Lisoni FC, Tajara EH, Oliani SM.

PLoS One. 2014 Dec 9;9(12):e111317. doi: 10.1371/journal.pone.0111317. eCollection 2014.

4.

Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling.

Bena S, Brancaleone V, Wang JM, Perretti M, Flower RJ.

J Biol Chem. 2012 Jul 13;287(29):24690-7. doi: 10.1074/jbc.M112.377101. Epub 2012 May 18.

5.

Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke.

Smith HK, Gil CD, Oliani SM, Gavins FN.

FASEB J. 2015 May;29(5):2161-71. doi: 10.1096/fj.14-263160. Epub 2015 Feb 17.

PMID:
25690650
6.

Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.

Dalli J, Consalvo AP, Ray V, Di Filippo C, D'Amico M, Mehta N, Perretti M.

J Immunol. 2013 Jun 15;190(12):6478-87. doi: 10.4049/jimmunol.1203000. Epub 2013 May 17.

7.

Annexin 1 exerts anti-nociceptive effects after peripheral inflammatory pain through formyl-peptide-receptor-like 1 in rat dorsal root ganglion.

Pei L, Zhang J, Zhao F, Su T, Wei H, Tian J, Li M, Shi J.

Br J Anaesth. 2011 Dec;107(6):948-58. doi: 10.1093/bja/aer299. Epub 2011 Oct 11.

8.

Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.

Hanson J, Ferreirós N, Pirotte B, Geisslinger G, Offermanns S.

Biochem Pharmacol. 2013 Jun 15;85(12):1795-802. doi: 10.1016/j.bcp.2013.04.019. Epub 2013 May 1.

PMID:
23643932
9.

Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system.

Gavins FN, Hughes EL, Buss NA, Holloway PM, Getting SJ, Buckingham JC.

FASEB J. 2012 Dec;26(12):4977-89. doi: 10.1096/fj.12-205971. Epub 2012 Sep 10.

PMID:
22964301
10.

Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation.

McArthur S, Gobbetti T, Kusters DH, Reutelingsperger CP, Flower RJ, Perretti M.

J Immunol. 2015 Aug 1;195(3):1139-51. doi: 10.4049/jimmunol.1500733. Epub 2015 Jun 22.

11.

Enhanced neutrophil expression of annexin-1 in coronary artery disease.

Särndahl E, Bergström I, Nijm J, Forslund T, Perretti M, Jonasson L.

Metabolism. 2010 Mar;59(3):433-40. doi: 10.1016/j.metabol.2009.07.044. Epub 2009 Oct 21.

PMID:
19850308
12.

Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement.

Hayhoe RP, Kamal AM, Solito E, Flower RJ, Cooper D, Perretti M.

Blood. 2006 Mar 1;107(5):2123-30. Epub 2005 Nov 8.

13.

Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis.

Vong L, Ferraz JG, Dufton N, Panaccione R, Beck PL, Sherman PM, Perretti M, Wallace JL.

PLoS One. 2012;7(6):e39244. doi: 10.1371/journal.pone.0039244. Epub 2012 Jun 18.

14.

Mast cells mediate early neutrophil recruitment and exhibit anti-inflammatory properties via the formyl peptide receptor 2/lipoxin A4 receptor.

Hughes EL, Becker F, Flower RJ, Buckingham JC, Gavins FNE.

Br J Pharmacol. 2017 Jul;174(14):2393-2408. doi: 10.1111/bph.13847. Epub 2017 Jun 10.

PMID:
28471519
15.

Epigenetic regulation of the formyl peptide receptor 2 gene.

Simiele F, Recchiuti A, Patruno S, Plebani R, Pierdomenico AM, Codagnone M, Romano M.

Biochim Biophys Acta. 2016 Oct;1859(10):1252-8. doi: 10.1016/j.bbagrm.2016.07.007. Epub 2016 Jul 14.

PMID:
27424221
16.

Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.

Planagumà A, Domenech T, Jover I, Ramos I, Sentellas S, Malhotra R, Miralpeix M.

Clin Exp Immunol. 2013 Aug;173(2):298-309. doi: 10.1111/cei.12110.

17.

Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.

Dufton N, Hannon R, Brancaleone V, Dalli J, Patel HB, Gray M, D'Acquisto F, Buckingham JC, Perretti M, Flower RJ.

J Immunol. 2010 Mar 1;184(5):2611-2619. doi: 10.4049/jimmunol.0903526. Epub 2010 Jan 27. Erratum in: J Immunol. 2011 Feb 15;186(4):2684-5.

18.

Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses.

Cooray SN, Gobbetti T, Montero-Melendez T, McArthur S, Thompson D, Clark AJ, Flower RJ, Perretti M.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18232-7. doi: 10.1073/pnas.1308253110. Epub 2013 Oct 9.

19.

Targeting the annexin 1-formyl peptide receptor 2/ALX pathway affords protection against bacterial LPS-induced pathologic changes in the murine adrenal cortex.

Buss NA, Gavins FN, Cover PO, Terron A, Buckingham JC.

FASEB J. 2015 Jul;29(7):2930-42. doi: 10.1096/fj.14-268375. Epub 2015 Mar 27.

PMID:
25818588
20.

FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.

Maderna P, Cottell DC, Toivonen T, Dufton N, Dalli J, Perretti M, Godson C.

FASEB J. 2010 Nov;24(11):4240-9. doi: 10.1096/fj.10-159913. Epub 2010 Jun 22.

Supplemental Content

Support Center